A drug already on the market that treats immune disorders may help stabilize patients with Alzheimer’s disease for up to three years, according to the results of a tiny study presented at a conference on Tuesday.All four patients who received the optimal dose of the drug, Gammagard from Baxter Inter

(Reuters) – India’s highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the country’s healthcare sector and potentially curb its global role as a supplier of cut-price generic medicines.The Supreme Court hearing pits Swiss d

Setting priorities for health interventions in developing countries: a review of empirical studies. Sitaporn Youngkong 1,2 Lydia Kapiriri 3 Rob Baltussen 1 1 Nijmegen International Center for Health Systems Research and Education (NICHE), Department of Primary and Community Care, Radboud Universit

A federal health official’s ruling has cleared the way for 50 different types of cancer to be added to the list of sicknesses covered by a $4.3 billion fund set up to compensate and treat people exposed to the toxic smoke, dust and fumes in the months after the Sept. 11, 2001, terrorist attacks.The

(Reuters) – Sanofi’s experimental pill to treat Gaucher disease, a rare inherited condition, has met its main goal in a late-stage trial, the French drugmaker said on Tuesday.Patients treated with the drug, eliglustat tartrate, showed a statistically significant improvement in the size of their sple

After decades of controversy, the Food and Drug Administration approved a new H.I.V. test on Tuesday that for the first time makes it possible for Americans to learn in the privacy of their homes whether they are infected.The availability of an H.I.V. test as easy to use as a home-pregnancy kit is y

Even in health care systems in which doctors do not bill for each test they administer, the use of diagnostic imaging like CT and PET scans has soared, as has patients’ radiation exposure, a new study has found.The study, published online on Tuesday in The Journal of the American Medical Association

SpeakerProfessor Dean Jamison, Professor Emeritus, Global Health Principal Investigator, Disease Control Priorities NetworkDate: 23 August 2016Time: 16.30 – 18.00Venue: Richmond Hotel, NonthaburiNumber of participants: 120 seats availableOrganizer: Health Intervention and Technology Assessment Progr

Abstract As COVID-19 ravages the world, many countries are faced with the grim reality of not having enough critical-care resources to go around. Knowing what could be in store, the Thai Ministry of Public Health called for the creation of an explicit protocol to determine how these resources are

The Health Protection Agency (HPA) has issued a warning about the dangers of picking poisonous mushrooms.It says foragers should be aware that it is easy to mix up toxic with non-toxic varieties.Dozens of people seek medical advice each year after eating wild mushrooms which they have picked themsel